GLIBENCLAMIDE Side Effects

6969123-7 | Anaemia, Body Temperature Increased, Chronic Myeloid Leukaemia, Discomfort, Epistaxis, Gastrointestinal Disorder, Gastrointestinal Haemorrhage, Platelet Count Decreased
on Aug 30, 2010 Female patient from UNITED STATES , weighting 117.0 lb, was treated with Glibenclamide (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, body temperature increased, chronic myeloid leukaemia, discomfort, epistaxis, gastrointestinal disorder, gastrointestinal haemorrhage, platelet count decreased. Glibenclamide dosage: Unk. During the same period patient was treated with METFORMIN HCL (Unk) (View Metformin Hcl Review and Metformin Hcl Label ), AZITHROMYCIN (Unk) (View Azithromycin Review and Azithromycin Label ), IRON (Unk) (View Iron Review and Iron Label ), PROTONIX (Unk) (View Protonix Review and Protonix Label ), NORVASC (View Norvasc Review and Norvasc Label ), BENICAR (View Benicar Review and Benicar Label ).

6917383-0 | Depressed Level Of Consciousness, Metabolic Acidosis, Pancreatitis Acute, Rectal Adenoma, Renal Failure Acute
Patient was taking Glibenclamide (View Usage). Patient had the following side effects: depressed level of consciousness, metabolic acidosis, pancreatitis acute, rectal adenoma, renal failure acute on Jul 15, 2010 from SPAIN Additional patient health information: Female patient , 74 years of age, was diagnosed with diabetes mellitus and. Glibenclamide dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6907868-5 | Depressed Level Of Consciousness, Metabolic Acidosis, Pancreatitis Acute, Rectal Adenoma, Renal Failure Acute
Adverse event was reported on Jul 15, 2010 by a Female patient taking Glibenclamide (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: SPAIN , 74 years of age, After Glibenclamide was administered, patient had the following side effects: depressed level of consciousness, metabolic acidosis, pancreatitis acute, rectal adenoma, renal failure acute. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6887504-7 |
on Jul 23, 2010 Male patient from UNITED STATES , 58 years of age, was treated with Glibenclamide (View Usage). . Glibenclamide dosage: . During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), JANUVIA (View Januvia Review and Januvia Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FLEXERIL (View Flexeril Review and Flexeril Label ).


6879928-9 |
on Jul 15, 2010 Female patient from UNITED STATES , 76 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Glibenclamide (View Usage). . Glibenclamide dosage: . During the same period patient was treated with IBANDRONIC ACID (View Ibandronic Acid Review and Ibandronic Acid Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), NORVASC (View Norvasc Review and Norvasc Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COZAAR (View Cozaar Review and Cozaar Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6792488-6 | Blood Glucose Decreased, Weight Increased
Patient was taking Glibenclamide (View Usage). After Glibenclamide was administered, patient had the following side effects: blood glucose decreased, weight increased on Aug 08, 2008 from UNITED STATES Additional patient health information: Female patient , 72 years of age, was diagnosed with diabetes mellitus and. Glibenclamide dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), PAXIL (View Paxil Review and Paxil Label ), GERITOL (View Geritol Review and Geritol Label ).

6785653-5 |
Adverse event was reported on Jun 16, 2010 by a Female patient taking Glibenclamide (View Usage) (Dosage: ) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: UNITED STATES , 76 years of age, . During the same period patient was treated with IBANDRONIC ACID (View Ibandronic Acid Review and Ibandronic Acid Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), NORVASC (View Norvasc Review and Norvasc Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COZAAR (View Cozaar Review and Cozaar Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6752801-2 | Hypoglycaemia, Intentional Overdose, Suicide Attempt
on May 19, 2010 Female patient from CANADA , 14 years of age, was diagnosed with suicide attempt and was treated with Glibenclamide (View Usage). Patient had the following side effects: hypoglycaemia, intentional overdose, suicide attempt. Glibenclamide dosage: . Patient was hospitalized.

6752800-0 | Hypoglycaemia, Intentional Overdose, Suicide Attempt
on May 19, 2010 Female patient from CANADA , 15 years of age, was diagnosed with suicide attempt and was treated with Glibenclamide (View Usage). After Glibenclamide was administered, patient had the following side effects: hypoglycaemia, intentional overdose, suicide attempt. Glibenclamide dosage: . Patient was hospitalized.

6742437-1 | Blood Glucose Increased, Erythema, Glucose Urine Present, Oedema Peripheral, Psoriasis, Weight Decreased
Patient was taking Glibenclamide (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, erythema, glucose urine present, oedema peripheral, psoriasis, weight decreased on Nov 03, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 165.3 lb, was diagnosed with psoriasis and. Glibenclamide dosage: . During the same period patient was treated with INSULIN (Dose As Used) (View Insulin Review and Insulin Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), PREDNISONE TAB (Dose As Used: Unk) (View Prednisone Tab Review and Prednisone Tab Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ).

6719684-8 | Hypoglycaemia
Adverse event was reported on Apr 22, 2010 by a Female patient taking Glibenclamide (View Usage) (Dosage: Po) was diagnosed with diabetes mellitus and. Location: JAPAN , 74 years of age, Patient had the following side effects: hypoglycaemia. During the same period patient was treated with PITAVASTATIN (View Pitavastatin Review and Pitavastatin Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ), BENIDIPINE HYDROCHLORIDE (View Benidipine Hydrochloride Review and Benidipine Hydrochloride Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ACARBOSE (View Acarbose Review and Acarbose Label ), PIOGLITAZONE HCL (View Pioglitazone Hcl Review and Pioglitazone Hcl Label ).

6715830-0 | Hypoglycaemia, Renal Failure Acute
on Apr 27, 2010 Female patient from GERMANY , 77 years of age, weighting 209.4 lb, was diagnosed with type 2 diabetes mellitus, hypertension, renal impairment, ischaemic heart disease prophylaxis, prophylaxis against gastrointestinal ulcer, hyperlipidaemia and was treated with Glibenclamide (View Usage). After Glibenclamide was administered, patient had the following side effects: hypoglycaemia, renal failure acute. Glibenclamide dosage: 1.75 Mg, 1x/day. During the same period patient was treated with METFORMIN HYDROCHLORIDE (500 Mg, 2x/day) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), LISINOPRIL (10 Mg, 1x/day) (View Lisinopril Review and Lisinopril Label ), FURORESE (60 Mg, 1x/day) (View Furorese Review and Furorese Label ), METOPROLOL (100 Mg, 2x/day) (View Metoprolol Review and Metoprolol Label ), ACETYLSALICYLIC ACID (100 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), PANTOZOL (40 Mg, 1x/day) (View Pantozol Review and Pantozol Label ), SIMVASTATIN (40 Mg, 1x/day) (View Simvastatin Review and Simvastatin Label ), XIPAMIDE (20 Mg, 2x/day) (View Xipamide Review and Xipamide Label ). Patient was hospitalized.

6715013-4 | Hypoglycaemia, Renal Failure Acute
on Apr 23, 2010 Female patient from GERMANY , 77 years of age, weighting 209.4 lb, was diagnosed with type 2 diabetes mellitus, renal impairment, hypertension, ischaemic heart disease prophylaxis, prophylaxis against gastrointestinal ulcer, hyperlipidaemia and was treated with Glibenclamide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, renal failure acute. Glibenclamide dosage: 1.75 Mg, Qd. During the same period patient was treated with FURORESE (60 Mg, Qd) (View Furorese Review and Furorese Label ), METFORMIN (500 Mg, Bid) (View Metformin Review and Metformin Label ), XIPAMIDE (20 Mg, Bid) (View Xipamide Review and Xipamide Label ), LISINOPRIL (10 Mg, Qd) (View Lisinopril Review and Lisinopril Label ), METOPROLOL (100 Mg, Bid) (View Metoprolol Review and Metoprolol Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), PANTOZOL (40 Mg, Qd) (View Pantozol Review and Pantozol Label ), SIMVASTATIN (40 Mg, Qd) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6714560-9 | Hypoglycaemia, Renal Failure Acute
Patient was taking Glibenclamide (View Usage). Patient had the following side effects: hypoglycaemia, renal failure acute on Apr 23, 2010 from GERMANY Additional patient health information: Female patient , 77 years of age, was diagnosed with type 2 diabetes mellitus, renal impairment, hypertension, ischaemic heart disease prophylaxis, prophylaxis against gastrointestinal ulcer and. Glibenclamide dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), FURORESE (View Furorese Review and Furorese Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6714559-2 | Hypoglycaemia, Renal Failure Acute
Adverse event was reported on Apr 23, 2010 by a Female patient taking Glibenclamide (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, renal impairment, hypertension, ischaemic heart disease prophylaxis, prophylaxis against gastrointestinal ulcer and. Location: GERMANY , 77 years of age, After Glibenclamide was administered, patient had the following side effects: hypoglycaemia, renal failure acute. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), FURORESE (View Furorese Review and Furorese Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6714558-0 | Hypoglycaemia, Renal Failure Acute
on Apr 23, 2010 Female patient from GERMANY , 77 years of age, was diagnosed with type 2 diabetes mellitus, renal impairment, hypertension, ischaemic heart disease prophylaxis, prophylaxis against gastrointestinal ulcer and was treated with Glibenclamide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, renal failure acute. Glibenclamide dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), FURORESE (View Furorese Review and Furorese Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6714556-7 | Hypoglycaemia, Renal Failure Acute
on Apr 23, 2010 Female patient from GERMANY , 77 years of age, was diagnosed with type 2 diabetes mellitus, renal impairment, hypertension, ischaemic heart disease prophylaxis, prophylaxis against gastrointestinal ulcer and was treated with Glibenclamide (View Usage). Patient had the following side effects: hypoglycaemia, renal failure acute. Glibenclamide dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), FURORESE (View Furorese Review and Furorese Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6714555-5 | Hypoglycaemia, Renal Failure Acute
Patient was taking Glibenclamide (View Usage). After Glibenclamide was administered, patient had the following side effects: hypoglycaemia, renal failure acute on Apr 23, 2010 from GERMANY Additional patient health information: Female patient , 77 years of age, was diagnosed with type 2 diabetes mellitus, renal impairment, hypertension, ischaemic heart disease prophylaxis, prophylaxis against gastrointestinal ulcer and. Glibenclamide dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), FURORESE (View Furorese Review and Furorese Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6702267-3 | Confusional State, Hypoglycaemia, Renal Failure Acute
Adverse event was reported on Apr 26, 2010 by a Female patient taking Glibenclamide (View Usage) (Dosage: ) . Location: GERMANY , 77 years of age, weighting 209.4 lb, Patient experienced the following unwanted or unexpected effects: confusional state, hypoglycaemia, renal failure acute. During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), FURORESE (View Furorese Review and Furorese Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASS ^CT ARZNEIMITTEL^ (Unit Dose: 100 Unk) (View Ass ^ct-arzneimittel^ Review and Ass ^ct-arzneimittel^ Label ), PANTOZOL (Unit Dose: 40 Mg) (View Pantozol Review and Pantozol Label ), SIMVASTATIN (Unit Dose: 40 Mg) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6644747-5 |
on Mar 11, 2010 Female patient from UNITED STATES , 76 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Glibenclamide (View Usage). . Glibenclamide dosage: . During the same period patient was treated with IBANDRONIC ACID (View Ibandronic Acid Review and Ibandronic Acid Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), NORVASC (View Norvasc Review and Norvasc Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COZAAR (View Cozaar Review and Cozaar Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6618950-4 | Confusional State, Hypoglycaemia, Renal Failure Acute
on Mar 18, 2009 Female patient from GERMANY , 77 years of age, weighting 209.4 lb, was diagnosed with myocardial infarction and was treated with Glibenclamide (View Usage). After Glibenclamide was administered, patient had the following side effects: confusional state, hypoglycaemia, renal failure acute. Glibenclamide dosage: . During the same period patient was treated with METFORMIN HYDROCHLORIDE (Dose Text: 500 Mg 2 In Day) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), METOPROLOL TARTRATE (Dose Text: 100 Mg, 2 In Day) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FURORESE (Dose Text: 60 Mg In 1 Day) (View Furorese Review and Furorese Label ), ACETYLSALICYLIC ACID (Unit Dose: 100 Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), PANTOZOL (Unit Dose: 40 Mg) (View Pantozol Review and Pantozol Label ), SIMVASTATIN (Unit Dose: 40 Mg) (View Simvastatin Review and Simvastatin Label ), XIPAMIDE (Dose Text: 20 Mg, Oral 2 In Day) (View Xipamide Review and Xipamide Label ). Patient was hospitalized.

6618821-3 | Blood Glucose Increased, Hypoglycaemia
Patient was taking Glibenclamide (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, hypoglycaemia on Feb 18, 2010 from JAPAN Additional patient health information: Female patient , 74 years of age, was diagnosed with diabetes mellitus and. Glibenclamide dosage: Po. During the same period patient was treated with PITAVASTATIN (View Pitavastatin Review and Pitavastatin Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ), BENIDIPINE HYDROCHLORIDE (View Benidipine Hydrochloride Review and Benidipine Hydrochloride Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), ACARBOSE (View Acarbose Review and Acarbose Label ), PIOGLITAZONE HCL (View Pioglitazone Hcl Review and Pioglitazone Hcl Label ).

6536670-1 | Completed Suicide
Adverse event was reported on Jan 04, 2010 by a Male patient taking Glibenclamide (View Usage) (Dosage: ) . Location: UNITED STATES , 54 years of age, Patient had the following side effects: completed suicide. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), METFORMIN (View Metformin Review and Metformin Label ), ROSIGLITAZONE (View Rosiglitazone Review and Rosiglitazone Label ).

6536666-X | Completed Suicide
on Jan 04, 2010 Male patient from UNITED STATES , 67 years of age, was treated with Glibenclamide (View Usage). After Glibenclamide was administered, patient had the following side effects: completed suicide. Glibenclamide dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ).

6536663-4 |
on Jan 04, 2010 Female patient from UNITED STATES , 70 years of age, was treated with Glibenclamide (View Usage). . Glibenclamide dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ).

6480852-4 | Glomerulonephritis Membranous, Renal Vein Thrombosis
Patient was taking Glibenclamide (View Usage). Patient had the following side effects: glomerulonephritis membranous, renal vein thrombosis on Nov 30, 2009 from UNITED STATES Additional patient health information: Male patient , 61 years of age, . Glibenclamide dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

6479896-8 | Hypoglycaemic Unconsciousness, Intentional Overdose, Suicide Attempt
Adverse event was reported on Nov 12, 2009 by a Female patient taking Glibenclamide (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 15 years of age, After Glibenclamide was administered, patient had the following side effects: hypoglycaemic unconsciousness, intentional overdose, suicide attempt.

6467555-7 | Cerebrovascular Accident, Myelopathy, Vitamin B12 Deficiency
on Nov 18, 2009 Male patient from UNITED STATES , 68 years of age, was diagnosed with type 2 diabetes mellitus, vitamin b12 deficiency and was treated with Glibenclamide (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, myelopathy, vitamin b12 deficiency. Glibenclamide dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ). Patient was hospitalized.

6452579-6 | Cerebrovascular Accident, Myelopathy, Vitamin B12 Deficiency
on Nov 17, 2009 Male patient from UNITED KINGDOM , 68 years of age, was diagnosed with type 2 diabetes mellitus, vitamin b12 deficiency and was treated with Glibenclamide (View Usage). Patient had the following side effects: cerebrovascular accident, myelopathy, vitamin b12 deficiency. Glibenclamide dosage: . During the same period patient was treated with METFORMIN HCL (2 G, Unk) (View Metformin Hcl Review and Metformin Hcl Label ), VITAMIN B 12 (Unk) (View Vitamin B-12 Review and Vitamin B-12 Label ). Patient was hospitalized.

6437700-8 | Circulatory Collapse, Constipation, Large Intestinal Obstruction, Multi-organ Failure, Myoclonus, Salivary Hypersecretion
Patient was taking Glibenclamide (View Usage). After Glibenclamide was administered, patient had the following side effects: circulatory collapse, constipation (What is constipation?), large intestinal obstruction, multi-organ failure, myoclonus, salivary hypersecretion on Oct 14, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 63 years of age, was diagnosed with hypothyroidism, schizophrenia, constipation (What is constipation?) and. Glibenclamide dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ). Patient was hospitalized.

6419737-8 | Hypoglycaemia
Adverse event was reported on Oct 20, 2009 by a Female patient taking Glibenclamide (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: , 76 years of age, Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Patient was hospitalized.

6397319-4 | Abdominal Pain, Ascites, Diarrhoea, Hepatic Cirrhosis, Varices Oesophageal
on Sep 28, 2009 Female patient from UNITED STATES , 62 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glibenclamide (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), ascites, diarrhoea, hepatic cirrhosis, varices oesophageal. Glibenclamide dosage: . During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6397318-2 | Hepatic Cirrhosis
on Sep 28, 2009 Female patient from UNITED STATES , 36 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glibenclamide (View Usage). After Glibenclamide was administered, patient had the following side effects: hepatic cirrhosis. Glibenclamide dosage: . During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ).

6340679-0 | Myocardial Infarction
Patient was taking Glibenclamide (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction on Aug 24, 2009 from UNITED STATES Additional patient health information: Female patient , 76 years of age, . Glibenclamide dosage: . During the same period patient was treated with BONIVA (View Boniva Review and Boniva Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), NORVASC (View Norvasc Review and Norvasc Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COZAAR (View Cozaar Review and Cozaar Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6340639-X | Acinetobacter Infection, Candiduria, Cytomegalovirus Enteritis, Renal Failure, Respiratory Failure, Staphylococcal Infection
Adverse event was reported on Aug 26, 2009 by a Male patient taking Glibenclamide (View Usage) (Dosage: ) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: PORTUGAL , 66 years of age, Patient had the following side effects: acinetobacter infection, candiduria, cytomegalovirus enteritis, renal failure, respiratory failure, staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), GANCICLOVIR (Dose: 5 Mg/kg) (View Ganciclovir Review and Ganciclovir Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6334930-0 | Myocardial Infarction
on Aug 21, 2009 Female patient from UNITED STATES , 76 years of age, was treated with Glibenclamide (View Usage). After Glibenclamide was administered, patient had the following side effects: myocardial infarction. Glibenclamide dosage: . During the same period patient was treated with BONIVA (View Boniva Review and Boniva Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), NORVASC (View Norvasc Review and Norvasc Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COZAAR (View Cozaar Review and Cozaar Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6331263-3 |
on Aug 17, 2009 Female patient from UNITED STATES , 76 years of age, was treated with Glibenclamide (View Usage). . Glibenclamide dosage: . During the same period patient was treated with BONIVA (View Boniva Review and Boniva Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), NORVASC (View Norvasc Review and Norvasc Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COZAAR (View Cozaar Review and Cozaar Label ).

6331262-1 | Depressed Level Of Consciousness, Pancreatitis Acute, Rectal Adenoma, Renal Failure Acute
Patient was taking Glibenclamide (View Usage). Patient had the following side effects: depressed level of consciousness, pancreatitis acute, rectal adenoma, renal failure acute on May 25, 2007 from SPAIN Additional patient health information: Female patient , 74 years of age, was diagnosed with diabetes mellitus and. Glibenclamide dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6308523-5 | Hypoglycaemic Encephalopathy
Adverse event was reported on Aug 10, 2009 by a Female patient taking Glibenclamide (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: JAPAN , 94 years of age, After Glibenclamide was administered, patient had the following side effects: hypoglycaemic encephalopathy.

6287212-X | Accidental Exposure, Hemiparesis, Mental Status Changes
on Jul 28, 2009 Female patient from UNITED STATES , child 6 years of age, was treated with Glibenclamide (View Usage). Patient experienced the following unwanted or unexpected effects: accidental exposure, hemiparesis, mental status changes. Glibenclamide dosage: . Patient was hospitalized.

6274557-2 | Base Excess, Blood Potassium Increased, Blood Pressure Increased, Circulatory Collapse, Gastroenteritis, Haemodialysis, Hyperventilation, Hypoglycaemia
on Apr 03, 2007 Female patient from NORWAY , 49 years of age, was diagnosed with hypertension and was treated with Glibenclamide (View Usage). Patient had the following side effects: base excess, blood potassium increased, blood pressure increased, circulatory collapse, gastroenteritis (What is gastroenteritis?), haemodialysis, hyperventilation, hypoglycaemia. Glibenclamide dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6270504-8 | Hypertension, Hypoglycaemia, Poisoning
Patient was taking Glibenclamide (View Usage). After Glibenclamide was administered, patient had the following side effects: hypertension, hypoglycaemia, poisoning (What is poisoning?) on Jul 09, 2009 from SPAIN Additional patient health information: Female patient , 49 years of age, was diagnosed with hypertension and. Glibenclamide dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), KETOCONAZOLE (View Ketoconazole Review and Ketoconazole Label ).

6241862-5 | Accidental Exposure, Hemiparesis, Mental Status Changes
Adverse event was reported on Jun 11, 2009 by a Female patient taking Glibenclamide (View Usage) (Dosage: ) . Location: UNITED STATES , child 6 years of age, Patient experienced the following unwanted or unexpected effects: accidental exposure, hemiparesis, mental status changes. Patient was hospitalized.

6238838-0 | Hypoglycaemia
on Jun 10, 2009 Female patient from UNITED KINGDOM , child 2 years of age, was treated with Glibenclamide (View Usage). Patient had the following side effects: hypoglycaemia. Glibenclamide dosage: . Patient was hospitalized.

6212045-X | Haemolytic Anaemia, Hypertension, Hypoglycaemia, Poisoning, Thrombocytopenia
on May 08, 2009 Female patient from SPAIN , 49 years of age, was diagnosed with hypertension and was treated with Glibenclamide (View Usage). After Glibenclamide was administered, patient had the following side effects: haemolytic anaemia, hypertension, hypoglycaemia, poisoning (What is poisoning?), thrombocytopenia. Glibenclamide dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), ALOSITOL (View Alositol Review and Alositol Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), CARDENALIN (View Cardenalin Review and Cardenalin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ).

6208789-6 | Confusional State, Hypoglycaemia, Renal Failure Acute
Patient was taking Glibenclamide (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, hypoglycaemia, renal failure acute on Mar 24, 2009 from GERMANY Additional patient health information: Female patient , 77 years of age, weighting 209.4 lb, was diagnosed with type 2 diabetes mellitus and. Glibenclamide dosage: . During the same period patient was treated with MESCORIT (View Mescorit Review and Mescorit Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FURORESE /00032601/ (View Furorese /00032601/ Review and Furorese /00032601/ Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), SIMVASTATIN (Dose: Unk) (View Simvastatin Review and Simvastatin Label ), PANTOZOL /01263202/ (Dose: Unk) (View Pantozol /01263202/ Review and Pantozol /01263202/ Label ), ASPIRIN (Dose: Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6202117-8 | Hypertension, Hypoglycaemia, Poisoning
Adverse event was reported on Apr 14, 2009 by a Female patient taking Glibenclamide (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: SPAIN , 49 years of age, Patient had the following side effects: hypertension, hypoglycaemia, poisoning (What is poisoning?). During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), KETOCONAZOLE (View Ketoconazole Review and Ketoconazole Label ).

6193663-4 | Delirium, Hepatitis, Lactic Acidosis, Tachypnoea
on May 04, 2009 Male patient from ITALY , 77 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glibenclamide (View Usage). After Glibenclamide was administered, patient had the following side effects: delirium, hepatitis (What is hepatitis?), lactic acidosis, tachypnoea. Glibenclamide dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ERLOTINIB (View Erlotinib Review and Erlotinib Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6191634-5 | Hypoglycaemia, Renal Failure Acute
on May 15, 2009 Female patient from GERMANY , 77 years of age, was diagnosed with renal impairment, hypertension, ischaemic heart disease prophylaxis, prophylaxis against gastrointestinal ulcer, hyperlipidaemia and was treated with Glibenclamide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, renal failure acute. Glibenclamide dosage: 1.75 Mg, 1x/day. During the same period patient was treated with METFORMIN HCL (500 Mg, 2x/day) (View Metformin Hcl Review and Metformin Hcl Label ), LISINOPRIL (10 Mg, 1x/day) (View Lisinopril Review and Lisinopril Label ), FURORESE (60 Mg, 1x/day) (View Furorese Review and Furorese Label ), METOPROLOL (100 Mg, 2x/day) (View Metoprolol Review and Metoprolol Label ), ACETYLSALICYLIC ACID (100 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), PANTOZOL (40 Mg, 1x/day) (View Pantozol Review and Pantozol Label ), SIMVASTATIN (40 Mg, 1x/day) (View Simvastatin Review and Simvastatin Label ), XIPAMIDE (20 Mg, 2x/day) (View Xipamide Review and Xipamide Label ). Patient was hospitalized.

6165359-6 | Cardiac Arrest, Torsade De Pointes
Patient was taking Glibenclamide (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), torsade de pointes on Apr 13, 2009 from GREECE Additional patient health information: Female patient , 67 years of age, . Glibenclamide dosage: . During the same period patient was treated with INDAPAMIDE (View Indapamide Review and Indapamide Label ).